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Abstract Following a skin injury, the damaged tissue is
repaired through the coordinated biological actions that
constitute the cutaneous healing response. In mammals,
repaired skin is not identical to intact uninjured skin,
however, and this disparity may be caused by differences in
the mechanisms that regulate postnatal cutaneous wound
repair compared to embryonic skin development. Improv-
ing our understanding of the molecular pathways that are
involved in these processes is essential to generate new
therapies for wound healing complications. Here we focus
on the roles of several key developmental signaling path-
ways (Wnt/b-catenin, TGF-b, Hedgehog, Notch) in
mammalian cutaneous wound repair, and compare this to
their function in skin development. We discuss the varying
responses to cutaneous injury across the taxa, ranging from
complete regeneration to scar tissue formation. Finally, we
outline how research into the role of developmental path-
ways during skin repair has contributed to current wound
therapies, and holds potential for the development of more
effective treatments.
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Cutaneous wund healing and skin development
Cutaneous wound repair recapitulates embryonic skin
development in numerous aspects, in an attempt to restore the
integrity of the injured tissue. Both processes involve the
differentiation, migration, proliferation, and apoptosis of
various cell types to create the multilayered tissue that con-
stitutes the skin. Many of the same key signaling pathways
that are activated during embryonic skin development are
also activated during postnatal cutaneous wound repair; these
include the Wnt/b-catenin, Notch, Hedgehog, and various
growth factor/cytokine pathways. Furthermore, several
‘embryonic’ extracellular matrix (ECM) components, such
as Extra-Domain-A (EDA) fibronectin, are synthesized dur-
ing postnatal wound repair [1, 2]. Despite these similarities,
there are a number of important differences between the
molecular mechanisms that regulate postnatal cutaneous
wound repair and embryonic skin development, and these
may partly be responsible for the inability of repaired skin to
achieve its original uninjured state.
Repaired skin, which usually heals as a scar, is weaker
than intact skin, and contains a disorganized ECM com-
pared to nonwounded skin, and healing early gestational
fetal wounds [3–6]. Cutaneous wounds do not normally
show regeneration of hair follicles, although an exception
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has been documented in the case of large cutaneous wounds
[7]. As a result, postnatal mammalian skin repair is not
identical to the process of regeneration, in which the
regenerated tissue is almost indistinguishable from the
uninjured tissue [5, 8]. Part of the reason for this difference
is the inflammatory response, which is unique to postnatal
wound healing [4, 9]. While the inflammatory response is
crucial to protect the body from invading foreign organisms
at the injury site, many of the inflammatory cytokines and
growth factors released during this process promote fibrosis
and scar formation [10, 11]. Indeed, embryonic wounds
tend to heal without scarring, and it is believed that this is
due to the relative lack of an inflammatory response caused
by the absence of a fully developed immune system [4, 5,
9]. Though early fetal healing does incorporate growth
factors and cytokines, the expression profiles and concen-
trations of these molecules are different from those in scar-
forming late gestational and adult healing [4, 6, 9]. For
example, scarless fetal wound healing is characterized by
lower levels of transforming growth factor-b1 (TGF-b1),
and higher concentrations of TGF-b3, compared to scar-
forming wounds [6, 9]. Similarly, the composition and/or
levels of certain ECM components, such as hyaluronic acid,
fibronectin, and elastin, differ in fetal versus postnatal skin
[9, 12, 13], and may influence the healing outcome.
Additional insight into the mechanisms that cause
embryonic skin development and repair to differ from
postnatal mammalian skin healing are being elucidated by
studies of organisms such as amphibians, which regenerate
their injured tissue in a process analogous to development
[5, 8]. Enhancing our understanding of the molecular
pathways that are responsible for these differences is vital
for generating novel medical therapies to improve wound
healing and reduce scarring. Here, we discuss the role of
developmental signaling pathways in cutaneous wound
repair, with an emphasis on keratinocyte and fibroblast
behavior, and compare and contrast this with their roles in
skin development. We also outline the varying responses to
injury across the taxa, ranging from complete regeneration
to scar tissue formation. Finally, we discuss current clinical
applications that may improve wound healing via the
modulation of developmental pathways, and map out future
areas of research which remain to be addressed.
Stages of cutaneous wound healing
The skin is composed of two main layers: the superficial
layer, the epidermis, which functions as a barrier to the
external environment, and the deeper layer, the dermis,
which is composed of connective tissue, and provides the
skin with its mechanical properties. The epidermis consists
of a stratified keratinized epithelium that is interspersed
with hair follicles and glands [14–16]. Underlying the
Table 1 Summary of the stages of wound repair
Stage of healing Main processes References
Hemostasis and inflammation Hemostasis [3, 15, 17–19]
Vasoconstriction
Formation of fibrin clot
Inflammation
Release of cytokines and growth factors by platelets and immune
cells, and from the disrupted matrix
Invasion of inflammatory cells (neutrophils, monocytes-
macrophages)
Proliferation Dermis [1–3, 5, 15, 20, 23, 25, 27, 28, 30]
Release of growth factors by macrophages and fibroblasts
Fibroblast migration and proliferation
Synthesis of matrix proteins (fibronectin and collagen)
Angiogenesis
Epidermis
Keratinocyte migration, proliferation and differentiation
Contributions from hair follicle stem cells
Possible contribution from interfollicular epidermal stem cells
Remodeling Reorganization and remodeling of the ECM [3, 5, 18, 20, 32, 33]
Myofibroblast formation
Contraction of the wound
Cell apoptosis
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epidermis is the dermis, subdivided into the upper ‘papil-
lary’ dermis, and the lower ‘reticular’ dermis, which differ
in the density of their collagen fibers [16]. During cuta-
neous wound healing, the barrier and mechanical properties
of skin are restored by the actions of numerous cell types
which undergo proliferation, differentiation, migration and
apoptosis to rebuild the skin. Normal cutaneous wound
repair is characterized by three overlapping phases of
healing termed the inflammatory, proliferative, and
remodeling phases [3, 5, 14, 15] (Table 1; Fig. 1a).
Fig. 1 Proliferative phase of murine cutaneous wound healing.
a Illustrative histological section of a murine cutaneous wound
during the proliferative phase of repair. Healing dermis is enriched
with higher numbers of fibroblasts and macrophages compared to
intact skin. b The effect of the developmental signaling pathways on
keratinocyte behavior in epidermal closure, and fibroblast behavior
and matrix deposition in dermal reconstitution, respectively, is
depicted. Red arrows indicate a positive or stimulatory effect of a
pathway on a cell type/outcome. Blue ‘‘inhibitory’’ symbols indicate
an inhibitory effect. Solid lines indicate that the effect of a pathway on
each cell type and/or outcome is supported by substantial in vivo
evidence in the literature. Dotted lines indicate effects which either
lack sufficient in vivo evidence or are based mainly on in vitro work.
Dotted gray lines with a question mark indicate unknown or unclear
outcomes. Colored diagrams represent outcomes of pathways in each
cell type (or matrix deposition) that are supported by substantial in
vivo evidence in the literature. In contrast, gray diagrams represent
outcomes that are based mainly on in vitro evidence or require further
in vivo investigation; Gray diagrams linked by a simple dotted line
indicate that there is either no effect, or that the effect is not known.
Refer to the text for a detailed explanation of the effect of each
signaling pathway on keratinocyte and fibroblast behavior during
wound repair
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Hemostasis and inflammation
Hemostasis forms the immediate response to injury and
functions to prevent the loss of blood at the wound site.
Vascular injury initiates a cascade of events that terminates
in coagulation, and encompasses vascular constriction,
platelet aggregation and degranulation, and finally the
formation of a fibrin clot [3, 17, 18]. The fibrin clot also
acts as a provisional matrix for the initial migration of
inflammatory cells to the wound site [3, 17, 18]. Inflam-
matory cells, such as neutrophils and monocytes, are
attracted to the site of injury by cytokines, including TGF-
b and platelet-derived growth factor (PDGF), which are
released by platelets and from sites of sequestration in the
disrupted ECM [15, 17]. Neutrophils remove bacteria and/
or foreign objects from the wound and are followed by
monocytes, which subsequently differentiate into macro-
phages [19]. While macrophages phagocytose foreign
organisms, particles, and dead neutrophils, they also
release TGF-b and other cytokines, and thereby stimulate
the movement of fibroblasts and epithelial cells into the
wound [15, 19].
Proliferation
The proliferative phase of wound healing (Fig. 1a) is
characterized by re-epithelialization of the epidermis, and
by repair of the underlying dermal or mesenchymal layer.
This is accompanied by neovascularization. The dermis is
restored by invading and proliferating fibroblasts that
synthesize and secrete ECM proteins and also release
activating growth factors such as TGF-b1 [3, 11, 20].
During the proliferative phase of wound repair, fibroblasts
produce immature or ‘embryonic’ ECM variants such as
EDA fibronectin and type III collagen, as well as the col-
lagen type I that is normally found in adult skin [1–3, 20].
The invasion of fibroblasts into the wound is facilitated by
their secretion of ECM-cleaving matrix metalloproteinases
(MMPs) [15]. Epidermal keratinocytes express various
integrin receptors during wound repair and are thought to
use the provisional matrix as a substrate for re-epitheliali-
zation [21, 22]. Closure of the epithelial gap and restoration
of the epithelium is important as a barrier function, and this
is achieved by a combination of keratinocyte migration,
proliferation and differentiation [5, 23]. Different popula-
tions of hair follicle stem cells [24–26], both inside [27]
and outside of [28] the hair follicle bulge region, contribute
to re-epithelialization during wound repair. Interfollicular
epidermal stem cells [24, 29] may also participate in this
process. For example, Langton et al. [30] found that the tail
skin of wounded mutant mice that lack hair follicles still
exhibited (albeit delayed) re-epithelialization. However,
further research is needed to unravel the details of a
potential contribution by interfollicular stem cells during
wound healing.
Remodeling
The remodeling of the wound site, following deposition of
sufficient ECM and the closure of the epithelial gap,
changes the properties of the tissue. Wound fibroblasts at
this stage of the repair process tend to adopt a contractile
myofibroblast phenotype [31, 32]. Reorganization of the
wound tissue involves the degradation and replacement of
immature ECM such as EDA fibronectin and collagen type
III with collagen I, the organization of collagen I fibers into
bundles, and the apoptosis of a variety of cell types at the
wound site [3, 5, 15, 18, 20, 33]. Together, these changes
result in the contraction of the wound and the formation of
acellular scar tissue. The remodeling process can continue
indefinitely, and scar tissue does not achieve the strength of
intact uninjured skin [3, 15].
Developmental signaling pathways in mammalian
wound healing
Wnt and b-catenin signaling
Wnts are secreted glycoproteins that are important in many
fundamental cellular processes during development and in
the maintenance of homeostasis in the adult (reviewed in
references [34–37]). Wnt ligands signal through the
canonical or noncanonical Wnt signaling pathways,
depending on the context. The canonical Wnt signaling
pathway is mediated through b-catenin, while the nonca-
nonical Wnt signaling pathways, such as the planar-cell-
polarity and the Wnt-calcium pathway, are transduced by
alternate effectors independently of b-catenin [35, 38].
Here we focus on the canonical Wnt signaling pathway and
its key mediator, b-catenin (Fig. 1b; Table 2).
b-Catenin is a transcriptional coactivator that associates
with other transcription cofactors, such as the T cell factors/
lymphoid enhancer factors, to modulate gene expression in
a cell type-specific manner (reviewed in reference [36]). In
the absence of Wnt signaling, b-catenin is targeted for
proteasomal degradation via N-terminal serine and threo-
nine phosphorylation by a cytoplasmic destruction complex
that includes the factors casein kinase I, axin, adenomatous
polyposis coli protein, and glycogen synthase kinase (GSK)
3b [34–37]. GSK3b is a crucial signaling hub that lies
downstream of Wnt, growth factor, and integrin signaling
pathways, among others [39], and its activity, and thus that
of b-catenin, can also be regulated by these various path-
ways. Canonical Wnt signaling is initiated by Wnt binding
to membrane Frizzled and low-density lipoprotein receptor
2062 K. A. Bielefeld et al.
123
related protein 5/6 (LRP 5/6), which stimulates the down-
stream signaling mediator, Dishevelled [34–37].
Dishevelled in turn stabilizes b-catenin by inhibiting the
activity of its destruction complex [35], leading to increased
cytoplasmic and nuclear levels of b-catenin. In addition to
its role as a signaling molecule, b-catenin functions as a
structural protein and forms a component of the adherens
junctions that mediate cell–cell contacts [34, 40]. It can be
freed from this physical association by phosphorylation at
specific tyrosine residues [40].
Wnts are important mediators of skin development,
participating in various processes from development of the
dermis to the formation of skin appendages, such as hair
(reviewed in reference [41]). Dermis at different sites in the
body, such as the dorsal and ventral dermis, has different
origins, and dermal development precedes that of the skin
appendages [41, 42]. Canonical Wnt/b-catenin signaling is
required for the specification of both murine dorsal [43]
and ventral [44] dermis. In murine ventral dermis forma-
tion, b-catenin also plays a role in the survival of early
ventral dermal progenitor cells [44]. Later in embryonic
development, epithelial–mesenchymal interactions lead to
the formation of the hair follicle from the epidermal
placode, the precursor of the hair follicle [24, 41, 45]. Wnt/
b-catenin is essential for hair follicle development during
embryogenesis [24, 26, 46–48]. In addition, it is important
for differentiation of hair follicles postnatally [24, 26, 46,
49, 50].
Analogous to its function in skin development, Wnt and/
or b-catenin signaling plays an important role in various
aspects of cutaneous wound repair. As discussed below, it
is involved in the construction of epithelial structures and
in the reconstitution of the dermal compartment, where
b-catenin is a prominent regulator of fibroblast behavior.
Cutaneous wounds express various Wnts during the
early phases of healing, with transcripts from Wnts 1, 3, 4,
5a, and 10b present in murine whole cutaneous wounds up
to 7 days after wounding [51]. In the epithelium, Wnt10b
protein can be detected in migrating epithelial cells up to
3 days after wounding, while WNT 4, 5a, and 10b localize
to hair follicles [51]. Wnt 4 is expressed in the dermis,
although the time-course of its expression has been vari-
ously detected in different studies up to 30 h after
wounding [52] and up to 7 days after wounding [51].
Wnt signaling is crucial to the regeneration of hair fol-
licles following injury—a process which has been
documented only in large healing wounds [7]. The concept
that wound healing recapitulates embryonic development is
illustrated by the interesting finding that the source of new
follicles is not cells within the hair follicle stem cell niche
[7]. This suggests that injury can reprogram or endow other
epidermal cells with stem cell or embryonic properties [7].
Table 2 Comparative summary of the participation of developmental signaling pathways in mammalian skin development and repair
Signaling pathway Skin compartmenta Skin development Skin repair
Wnt/b-catenin Dermis Development of the dermis
[41, 43, 44]
Reconstitution of the dermis: fibroblast
numbers, cellularity; fibroblast behavior;




of hair follicles [24, 26, 46–48]
Regeneration of hair follicles in large wounds [7]
TGF-b1 Dermis Role to be deciphered; expressed
in developing dermis [217, 218]
Reconstitution of the dermis; fibroblast proliferation
and behavior; matrix production; myofibroblast




No significant role in hair follicle
development [84]
Inhibitory role in re-epithelialization [92, 102, 106]
Notch Dermis Role to be deciphered May be involved in dermal reconstitution:
macrophage behavior [130]; angiogenesis





Role to be deciphered
Sonic hedgehog Dermis Role to be deciphered; in non-
mammals (chick embryo), it
does not induce differentiation
of dermatome (precursor of
dermis) [219]
May be involved in dermal reconstitution:





of hair follicles [46, 132, 134,
135, 138]
Present in regenerated hair follicles
[7]; not expressed by wound
keratinocytes [142]
a ‘‘Epidermis and associated structures’’ includes the hair follicle and its associated structures (such as the dermal papilla).
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The role of Wnt/b-catenin signaling in wound re-epi-
thelialization is beginning to be unraveled. Primary
keratinocytes harvested from mice expressing conditionally
ablated or stabilized b-catenin alleles do not display sig-
nificant differences in migratory capacity in in vitro
experiments [53]. An inhibitory effect of b-catenin on
re-epithelialization has been suggested by a study that
observed enhanced epidermal nuclear accumulation of
b-catenin at the edge of chronic ulcers [54], and found that
pharmacological stabilization of b-catenin inhibited kerat-
inocyte migration in culture [54]. Though these studies
suggest that b-catenin does not promote keratinocyte
migration in vitro, further research is needed to elucidate
whether b-catenin or Wnt signaling actively influences
re-epithelialization of wounds in vivo.
b-Catenin is an important regulator of fibroblast
behavior during the proliferative phase of dermal wound
repair. b-Catenin protein levels and transcriptional activity
are elevated in dermal fibroblasts during the proliferative
phase of healing in murine cutaneous wounds and return to
baseline during the remodeling phase [55]. Human wounds
similarly show increased expression of b-catenin and its
target genes, such as fibronectin and MMP7, during the
proliferative phase [56]. Increased b-catenin expression
during wound repair has also been noted in other species,
such as in the horse [57]. The relative level and activity of
b-catenin contributes to the dermal wound phenotype, with
high b-catenin levels and activity leading to an enlarged,
hypercellular dermal compartment, and low levels of
b-catenin associated with a smaller and less cellular dermal
compartment [53]. This was demonstrated using mouse
models in which b-catenin can be conditionally stabilized
or ablated [53]. Similar to the hyperproliferative dermal
healing response that is observed in conditionally b-catenin
stabilized mice [53], mice with a fibroblast-specific con-
ditional deletion of GSK3b show elevated b-catenin levels
and a rapid and fibrotic wound healing response, that
includes increased dermal collagen deposition, scarring,
and myofibroblast formation [58]. The mechanism was
found to involve a b-catenin-dependent pathway [58, 59].
It has been recently shown that knockdown of b-catenin in
Pax7-expressing cells in murine wounds results in a
smaller scar size with fewer dermal fibroblast-like cells
[60]. In fact, approximately 25 % of dermal fibroblast-like
cells in healing wounds in mice are derived from Pax7-
expressing muscle progenitor cells that exhibit activated
b-catenin signaling [60]. While increased b-catenin activity
during the proliferative phase is crucial for successful
wound repair, prolonged or aberrant b-catenin activity
beyond the normal parameters of healing contributes to
excessive fibrosis and scar formation. Indeed human
hypertrophic scars and keloids exhibit elevated b-catenin
levels [56, 61].
Interestingly, while Wnt ligands may participate in
stimulating dermal b-catenin during wound repair, Wnt
signaling is not crucial for maintaining elevated b-catenin
levels during the proliferative phase of cutaneous healing
[62]. This has been demonstrated in mice treated with an
adenovirus expressing the Wnt signaling inhibitor Dick-
kopf (DKK1, which binds LRP6/Arrow [63]), which did
not show a significant decline in b-catenin protein levels
during the proliferative phase of skin wound healing [62],
in contrast to the situation in bone repair [64]. This sug-
gests that other factors play a role in regulating b-catenin
levels during the proliferative phase of healing. Indeed,
b-catenin levels in fibroblasts can be stimulated by growth
factors, such as TGF-b1 [53, 65, 66], that are released
during the early stages of wound repair. Furthermore,
b-catenin activity in dermal fibroblasts is regulated by
ECM components, such as fibronectin, which activate
b-catenin through a GSK3b-dependent, b1 integrin-medi-
ated pathway [62]. Integrins, which span the cell
membrane, are one of the major pathways of communi-
cation between the ECM and the cell interior [67, 68].
During the proliferative phase of wound repair, EDA
fibronectin-deficient mice display reduced b-catenin acti-
vation, fewer fibroblasts, and decreased wound strength
compared to wild-type littermates [62]. These characteris-
tics are rescued by genetic activation of b-catenin using an
EDA fibronectin-deficient mouse cross that also expresses
conditionally stabilized b-catenin, or through pharmaco-
logical stabilization of b-catenin using lithium chloride
[62]. This suggests that fibronectin regulates fibroblast
behavior through a b-catenin mediated mechanism during
wound repair [62]. ECM regulation of b-catenin during
wound healing has also been suggested by the finding that
wounds created by the novel Picsecond IR laser, which
causes minimal tissue or ECM damage compared to tra-
ditional surgical lasers, show decreased b-catenin and
TGF-b pathway activation compared to wounds created
using a surgical scalpel [69].
Mesenchymal progenitor cells also contribute to repair
in various contexts [70, 71]. As the differentiation state of
mesenchymal progenitor cells is tightly regulated by Wnt/
b-catenin signaling [70–72], changes in the level of sig-
naling activity may affect the repair process by impacting
differentiation of these cells. For instance, in bone repair,
altering b-catenin levels before pluripotent mesenchymal
progenitors cells have differentiated impairs healing [64].
In contrast, activating b-catenin levels once progenitors
have committed to the osteoblast lineage has a positive
effect on repair [64]. The impact of Wnt/b-catenin sig-
naling levels on mesenchymal progenitor differentiation is
also illustrated in the context of myocardial healing: in an
implantation model of myocardial repair, inhibition of Wnt
(and bone morphogenetic protein, BMP) signaling using
2064 K. A. Bielefeld et al.
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secreted frizzled-related protein-2 prevents differentiation
and apoptosis of bone marrow-derived mesenchymal pro-
genitor cells and improves their engraftment [73].
b-Catenin and Wnt signaling are intrinsically involved
in the formation of the dermis and of epidermal structures,
both during wound repair and during skin development. It
will be interesting to elucidate whether non-Wnt activators
of b-catenin, such as ECM proteins and growth factors,
modulate b-catenin during skin development as they do
during healing. In turn, the role of Wnt/b-catenin signaling
in terms of epidermal–mesenchymal interactions during
wound repair must be further explored. These reciprocal
interactions play a significant role during embryonic skin
development [41, 45], but have not yet been as thoroughly
investigated during wound healing. A recent study dem-
onstrated that adult dermis can be reprogrammed to regain
the characteristics of neonatal dermis in response to epi-
dermal stabilization of b-catenin [74], raising the issue of
whether similar or reciprocal interactions could take place
during wound repair. In that study, the remodeled dermis
was characterized by a downregulation of ECM genes,
expression of immature collagens, and increased prolifer-
ation of fibroblasts, and these responses were found to
originate from fibroblasts in the vicinity of the sebaceous
gland [74]. Another example of epidermal–mesenchymal
interactions in skin is illustrated by the finding that epi-
dermal hair follicle stem cells secrete the Wnt/b-catenin
target, Nephronectin, to form a specialized attachment site
for smooth muscle precursors of the arrector pili muscle
[75]. Thus, investigating whether Wnt and/or b-catenin
participate in epithelial–mesenchymal interactions during
wound repair is an important direction for future research.
TGF-b pathway
Numerous growth factors and cytokines participate in
wound repair. These include the TGF-bs, PDGFs, epider-
mal growth factors (EGFs), fibroblast growth factors
(FGFs), vascular endothelial growth factors (VEGFs), and
various proinflammatory cytokines, such as the interleukins
(reviewed in references [76, 77]). These factors are
released by various cell types as well as from sites of
sequestration in the disrupted ECM [77]. In this review, we
focus on TGF-bs, which are one of the major cytokine
mediators of cutaneous wound healing.
TGF-bs comprise the TGF-b1, TGF-b2 and TGF-b3
isoforms, and are part of the TGF-b superfamily that also
includes BMPs, among others [10, 78]. During wound
healing, TGF-bs are secreted by various cell types,
including macrophages and fibroblasts, and they are also
released from storage sites in the disrupted ECM [77, 79].
TGF-bs are secreted as inactive precursors bound to the
latency-associated and latent TGF-b binding proteins
[10, 79]. They are subsequently activated by the action of
proteases or through conformational changes induced by
integrins in response to cell traction forces [10, 79].
TGF-bs exert cell-specific effects by binding to serine/
threonine kinase TGF-b receptor I and TGF-b-receptor II
heterodimers, leading to the activation (phosphorylation) of
Smads 2 and 3, their association with the common medi-
ator Smad 4, and the subsequent translocation of this
complex to the nucleus where they may associate with
other transcription cofactors to modulate gene expression
[10, 11, 78–80]. Smad 7 is an antagonist to Smad
2/3-mediated signaling [10, 11, 78–80]. Mechanisms of
TGF-b signaling that do not involve Smads also exist,
including mitogen-activated protein kinase, Akt, extracel-
lular signal-regulated kinase, TGF-b-associated kinase I,
and small GTPases, among others [81–83].
Several members of the TGF-b superfamily, including
TGF-bs and BMPs, are involved in the development of
skin and/or skin appendages, such as hair follicles [78].
Studies involving mice deficient in different TGF-b iso-
forms have shown that TGF-b2 is required for murine hair
follicle development, while TGF-b1 and TGF-b3 do not
contribute significantly to this process [84]. In turn, addi-
tion of exogenous TGF-b1 to embryonic skin explants has
an inhibitory effect on hair follicle development
[84]. Using a keratinocyte-specific Smad7-overexpressing
mouse model, it was found that Smad-7 can interact with
b-catenin to influence both embryonic and adult hair fol-
licle morphogenesis by promoting its degradation via
recruitment of the E3 ligase, Smurf 2 [85]. However, the
relevance of this mechanism to hair follicle formation
under normal physiological conditions must be further
explored.
The TGF-b pathway is recognized for its ability to alter
the pace of healing. TGF-b1 is characterized as a fibrosis-
and scar-promoting factor, while TGF-b3 has been asso-
ciated with antiscarring actions [6, 86]. For instance,
Puolakkainen et al. [87] found that treatment of wounds in
aged rats with topical TGF-b1 improved several aspects of
dermal healing, including ECM deposition and fibroblast
influx and proliferation. TGF-b1 application also improved
angiogenesis, inflammatory cell infiltration, and epithelial
closure of the wounds [87]. Indeed, TGF-b1 signaling
plays a role in many fibrotic effects associated with wound
repair, including proliferation of fibroblasts [87, 88], syn-
thesis of ECM components such as collagen I [89] and
fibronectin [89, 90] by fibroblasts, transition of fibroblasts
to a myofibroblast wound phenotype [91], and contraction
of the wound [92]. Some of the fibrotic effects of TGF-b in
wound fibroblasts may be mediated through the matricel-
lular protein, connective tissue growth factor (CTGF or
CCN2) [93–97]. CCN2 is upregulated in response to
TGF-b signaling in fibroblasts during fibrotic conditions
Cutaneous healing: developmental pathways 2065
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such as wound repair, and it also cooperates with TGF-b to
mediate some of its effects, such as regulation of collagen
expression [93, 94, 97–99].
In vivo animal models, particularly genetically modified
mice, have contributed much of our understanding of the
fibrotic mechanisms of the TGF-b pathway during wound
repair. Mouse models deficient in TGF-b pathway signal-
ing components tend to exhibit defects in dermal healing.
For example, the dermis of Smad 3 knockout mice displays
fewer fibroblasts, reduced ECM deposition, and a smaller
wound area than control mice [100]. Similarly, wounds in
Tgfb1-/- Scid-/- mice heal with a thin and disorganized
dermis, and exhibit delays in all phases of wound healing
[101]. Both studies also showed a deficiency in inflam-
matory cells in the healing wounds [100, 101]. More recent
studies have utilized fibroblast-specific deletions of TGF-b
receptor II (TGF-bRII) to examine its effect on dermal
healing [92, 102]. These studies showed that ablation of
fibroblast TGF-bRII causes defects in the dermal ECM,
such as a reduction in granulation tissue formation,
increased scar size [102], and diminished collagen depo-
sition [92]. Fibroblasts cultured from TGF-bRII knockout
mice also display cytoskeletal abnormalities, and reduced
contractile abilities [92]. Thus, various mouse models
clearly demonstrate that TGF-b signaling is crucial in
mediating the fibrotic mechanisms needed to restore the
dermis during adult cutaneous wound repair.
While the profibrotic effects of TGF-b1 suggest that it
may promote re-epithelialization by stimulating matrix
formation for keratinocyte migration, TGF-b1 also has an
inhibitory effect on keratinocyte proliferation [103], sug-
gesting that it may impair this aspect of re-epithelialization.
In keeping with these different effects of TGF-b1 on
keratinocytes, contrasting roles for TGF-b pathway
involvement in re-epithelialization have been described in
the literature. For example, topical TGF-b1 administration
promotes epithelial wound closure in rats [87], and this is
complimentary to the delayed re-epithelialization observed
in double mutant Tgfb1-/- Scid-/- mice [101]. Similarly,
the wounds of a3b1 integrin-deficient mice display a lag in
re-epithelialization which is caused by a suppression of the
response to TGF-b1 signaling in keratinocytes via the
upregulation of inhibitory Smad 7 [104]. In contrast to
studies which have shown a positive role for the TGF-b1
pathway in epidermal closure, other research has demon-
strated a negative influence of TGF-b1 signaling on re-
epithelialization. For example, deletion of Smad3 in
genetically engineered mice results in accelerated epider-
mal closure and proliferation [100], and TGF-b antagonist
treatment of porcine burn wounds increased the number of
wounds that healed with complete re-epithelialization
[105]. Transgenic mice that overexpress the inhibitory
Smad, Smad-7, in the epidermis also exhibited more rapid
wound closure, increased keratinocyte proliferation, and in
vitro keratinocyte migration than controls [106].
Because TGF-b1 stimulates wound contraction [92,
107], it is possible that some of the seemingly contrasting
roles for the TGF-b pathway in re-epithelialization could
be caused, in part, by effects on wound contraction being
interpreted as epithelialization. Furthermore, different
TGF-b ligands and/or pathway components were manipu-
lated in various studies, which may in turn result in
different downstream effects. For instance, manipulation of
a signaling mediator, such as Smad, affects the signaling of
various upstream members of the TGF-b superfamily, and
thus influences the function of numerous pathways simul-
taneously. Crosstalk between different cell compartments,
or the relative balance of other signaling mediators, may
also be affected by different experimental conditions across
studies. In fact, the ultimate effect of TGF-b on re-epi-
thelialization may be determined by the balance of a
complex array of factors and conditions at the wound site.
TGF-b signaling during wound healing involves crosstalk
between the dermis and epidermis to influence the healing
outcome [108]. For example, while fibroblasts release growth
factors such as TGF-b that affect keratinocyte behavior
[103], keratinocytes can in turn downregulate TGF-b
expression by fibroblasts [109]. An influence of epidermal
TGF-b signaling on dermal healing is also suggested by a
recent study in transgenic mice that over-express Smad7 in
keratinocytes [106]. Cutaneous wounds from these mice
exhibit altered temporal expression of dermal collagen
compared to control mice, and effects on angiogenesis and
inflammatory cells were also observed [106]. In turn, mouse
models with a fibroblast-specific deletion of TGF-bRII show
changes in re-epithelialization, suggesting that dermal TGF-
b signaling influences epidermal behavior during wound
repair [92, 102]. For example, Denton et al. [102] and Mar-
tinez-Ferrer et al. [92] both observed increased keratinocyte
proliferation in fibroblast-specific TGF-bRII knockout
wounds, and Martinez-Ferrer et al. [92] also reported a
hypertrophic epidermis with increased keratin 5 expression.
While one study showed a faster rate of re-epithelialization in
fibroblast-specific TGF-RII knockout wounds during the
early phase of healing [92], another found that the two groups
of mice exhibited similar epithelial closure by the prolifera-
tive phase of healing [102]. These data support the concept
that there is crosstalk between the two skin compartments
during wound repair, and suggests that TGF-b signaling in
fibroblasts may normally exert some inhibitory effects on
keratinocyte behavior during healing.
While TGF-b1 stimulates the fibrotic effects necessary
for dermal healing, excessive TGF-b1 activity can lead to
the formation of hypertrophic scars, in part through
mechanisms mediated by b-catenin [53, 65] or CCN2
[110]. Indeed, TGF-b1 signaling has long been noted for its
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association with inflammation and fibrosis following
injury. One of the differences between adult and scarless
fetal wound healing is the near absence of TGF-b1 in the
early fetal repair process [4, 111]. The scar-promoting
effects of TGF-b1 are exemplified by the scarring remi-
niscent of adult wound repair caused by the application of
TGF-b1 to embryonic skin wounds [111]. In fact, scar-free
embryonic wounds in rats have lower TGF-b1 and higher
TGF-b3 levels than the scar-forming adult-like wounds that
occur in late gestation [6]. The effects of hypoxia on TGF-b3
[112, 113] may account for the increased TGF-b3 levels in
fetal versus adult healing. The application of TGF-b3 has
been shown to reduce scarring in a rodent wound model
[86], although some reports dispute the antiscarring abili-
ties of this molecule [114]. TGF-b3 has been reported to
reduce scar formation through effects on matrix produc-
tion, cell movement and inflammatory mediators [115].
However, the precise molecular mechanisms involved are
not clear. One possibility is raised by the finding that
human serum (which contains TGF-b3) promotes epithelial
migration, while plasma (which does not contain detectable
TGF-b3) encourages dermal fibroblast migration [116]. It
was suggested that the transition between these media (and
thus exposure to soluble TGF-b3) during wound healing
influences the motility of different cell types [116]. It is
conceivable that a related mechanism might operate during
fetal wound healing to differentially influence the behavior
of cells in different skin compartments exposed to TGF-b3.
However, research also suggests that the ability of fetal
wounds to heal without scarring is an inherent property that
does not depend on the fluid environment of the embryo
[9, 117]. The detailed mechanisms whereby TGF-b3 may
exert antiscarring actions await further investigation. Fur-
thermore, as noted above, whether TGF-b3 can act as a
potential antiscarring agent is controversial. While a
pharmaceutical formulation of TGF-b3 has shown promise
in improving the appearance of scars in phase II clinical
trials [118], the drug did not meet some of the expected
endpoints in phase III clinical trials [119].
Different components of the TGF-b signaling pathway
seem to be important in skin development and in postnatal
wound repair. For example, while TGF-b1 is a crucial
component of the fibrogenic aspect of postnatal healing, it
does not appear to play a significant role during embryonic
skin morphogenesis. In contrast, other TGF-b signaling
molecules or mediators, such as TGF-b2, participate in
mediating certain aspects of skin development, such as hair
follicle formation [78, 84].
Notch pathway
The Notch signaling pathway is a regulator of epidermal
differentiation, both in the maintenance of skin homeostasis
in the adult, and in embryonic development of the epidermis
[26, 120, 121]. It also plays a major role in other develop-
mental and physiological processes, including angiogenesis
and vascular maintenance [122]. Notch is known to engage
in crosstalk with the Wnt/b-catenin and Hedgehog path-
ways [120], two other signaling pathways that participate in
skin development and homeostasis. Notch signaling
requires an interaction between a transmembrane ligand and
the transmembrane Notch receptor on two adjacent cells
[120–122]. In mammals there are four Notch receptors, and
their ligands are members of the Delta-like and Jagged
families [120–122]. Ligand binding causes sequential pro-
teolytic cleavage of the Notch receptor, resulting in the
liberation of the Notch intracellular domain (NCID) from
the cell membrane and its translocation to the nucleus where
it associates with RBP-J and other cofactors to modulate the
transcription of target genes such as the Hes/Hey tran-
scriptional repressors [120–122].
During skin development, Notch signaling regulates
epidermal differentiation to ensure correct stratification of
the epidermis [26, 123, 124]. Interestingly, cilia are
involved in stimulating the Notch pathway during epider-
mal development, as demonstrated by the finding that mice
lacking epidermal cilia show attenuated Notch signaling
and impaired epidermal differentiation [125]. Some com-
ponents and/or modulators of Notch signaling are
expressed during development of dermal portions of the
skin: Delta1 [126, 127] and Lunatic Fringe [127] are
expressed in dermal condensates [126, 127], while Notch2
has been identified in the adjacent mesenchyme [127].
Research has suggested that the Notch pathway partic-
ipates in wound repair, and that it is required for proper
healing. Thelu et al. [128] described expression of Jagged1
and Notch1, as well as the signaling modulator, Lunatic
Fringe, in healing epidermis of wounded human skin
grafted onto mice [128]. Later studies examined the role of
the Notch pathway during wound repair. Transgenic mice
expressing a Notch antisense sequence that causes a 50 %
reduction in Notch protein, exhibited delayed healing as
assessed by surface wound size [129]. Mice treated with
the Notch ligand, Jagged, show accelerated wound closure
(as assessed by surface wound size) suggesting that these
effects are mediated by the Notch pathway [129]. In vitro
scratch wound assays with cultured cells, using a Notch
inhibitor or activator, suggest that part of the mechanism
may involve promigratory effects of Notch on fibroblast
and vascular endothelial cells [129]. In turn, Outtz et al.
[130] found that Notch1 hemizygous (heterozygous) mice
exhibit increased collagen deposition and vascularity in
healing wounds. The participation of Notch signaling in
angiogenesis during wound repair was also suggested by
Caiado et al. [131] following in vitro studies where
the Notch pathway regulated the matrix-adhering and
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angiogenic properties of bone marrow-derived vascular
precursor cells. Injection of such cells into mice caused a
reduction in the size of healing wounds and also increased
the density of wound microvessels, whereas mice that were
injected with cells treated with a Notch inhibitor did not
exhibit these effects [131].
Interestingly, a potential role for Notch signaling in the
wound inflammatory response, a process that does not exist
during development, has recently been elucidated. Outtz
et al. [130] utilized Notch1 hemizygous (heterozygous)
mice, as well as mice with a myeloid-specific deletion of
Notch1, to study the genetic effects of Notch1 deficiency
on macrophage function during wound repair. Both mouse
models exhibited reductions in macrophage recruitment
and in the expression of various inflammatory cytokines
and growth factors commonly secreted by macrophages
[130]. The data suggest a role for Notch in regulating
macrophage behavior during the inflammatory phase of
healing [130]. In particular, in vitro and in vivo studies
showed that Notch1 can modulate VEGF1 expression by
macrophages [130]. Interestingly, wounds from mice with
a myeloid-specific deletion of Notch1 did not show chan-
ges in the wound phenotype in terms of collagen deposition
or the number of blood vessels, in contrast to mice with a
general Notch1?/- deletion, where these parameters were
increased [130]. This suggested that cells other than mac-
rophages are involved in mediating some of the effects of
Notch1 on the wound phenotype [130].
There is evidence that the Notch pathway participates in
wound repair, and that it may be involved in several aspects
of healing, such as angiogenesis, matrix production, and
inflammation. However, the role of Notch signaling in wound
healing has not been as extensively studied as have some
other pathways, and there are still many questions to explore.
Some of the suggested roles for Notch signaling in healing are
quite different from its function in skin development. For
example, Notch’s involvement in macrophage behavior
during the inflammatory phase of wound repair is unique in
the sense that this function would not be utilized during
embryonic development. In addition, Notch is well known as
a regulator of epidermal differentiation of skin [26, 120, 121],
but its role in this process during the re-epithelialization of
healing wounds is relatively unexplored. In keeping with this,
any influence of Notch on the behavior of various cell
types, such as keratinocytes and fibroblasts, during healing
must also be investigated. Thus, there are many interesting
avenues of potential future research with regard to the
involvement of Notch signaling in cutaneous wound repair.
Hedgehog pathway
The Hedgehog signaling pathway is involved in many
aspects of embryonic development, including skin
morphogenesis and angiogenesis [132, 133]. In skin
development, it plays a significant role in the development
of hair follicles and associated structures such sebaceous
glands and the dermal papilla, as well as in the regulation
of hair follicle and epidermal stem cells in the adult [46,
132, 134–138]. Hedgehog, Wnt/b-catenin, and Notch sig-
naling interact in many of these processes. Three Hedgehog
proteins exist in mammals, termed Sonic Hedgehog (Shh),
Desert Hedgehog (Dhh), and Indian Hedgehog (Ihh) [132,
139]. Here we focus on Shh signaling. Shh binds to the
transmembrane protein and tumor suppressor, PTCH, to
de-repress the inhibition of Smoothened, resulting in acti-
vation of the Gli transcription factors and the regulation of
downstream target genes [132, 139].
While the Shh pathway’s involvement in skin develop-
ment has been extensively studied, much less is known
about its role in wound repair. Nevertheless, several recent
studies have begun to address this issue and suggest that
the Shh pathway may have the ability to modulate several
aspects of wound healing, such as dermal repair, and
wound vascularization [140, 141]. Shh is present in
regenerated hair follicles following wound healing [7], but
it is not expressed at detectable levels in wound epidermis
or in the keratinocytes that contribute to re-epithelialization
[142]. A study that used a reporter mouse expressing LacZ
upstream of Ptc1 to examine Shh pathway activation in
murine wounds, found Patch1 expression in hair follicles
close to the wound site and in the dermis adjacent to the
hair follicles [140]. The authors then tested the effects of
Shh on wound repair in diabetic mice using methylcellu-
lose pellets that contained a human Shh-expressing
plasmid. Topical application of the plasmid to mouse
wounds stimulated Shh expression in keratinocyte-like and
fibroblast-like cells [140]. Interestingly, diabetic mice
treated with Shh exhibited improvements in re-epitheliali-
zation and dermal healing, including a larger and more
collagen-rich dermal compartment, compared to control
mice [140]. The wounds of Shh-treated mice also exhibited
increased cellularity and vascularity [140]. The ‘fibrotic’
effects observed in Shh-treated wounds may be caused by
enhanced fibroblast activity, as Shh stimulated proliferation
of primary dermal fibroblasts in vitro [140]. Further, it was
found that Shh treatment increases both VEGF expression
and the recruitment of bone marrow-derived endothelial
progenitor cells to wound vasculature, suggesting a possi-
ble mechanism for the increased vascularity in Shh-treated
wounds [140]. Complimentary to these results, in a more
recent study, mice treated with the Shh inhibitor cyclop-
amine for 30 days after wounding showed delayed wound
closure and reduced dermal granulation tissue formation
[141]. In addition, wound vascularity and cell proliferation
were adversely affected in response to Shh inhibition [141].
Another study also found activation of the Shh pathway in
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murine cutaneous wounds, and treatment of diabetic mice
with topical Shh improved healing by modulating the nitric
oxide pathway [143].
Thus Shh has the potential to influence several aspects of
wound healing, including dermal tissue repair and vascu-
larization. Additional studies are required to elucidate the
mechanisms behind some of these effects and to define the
physiological role of Shh in wound repair more precisely,
including its function(s) in different cell types. One area of
interest would be to determine whether Shh signaling is a
participant in epithelial–mesenchymal interactions during
wound repair. Importantly, future research on Shh in wound
repair should be undertaken using appropriate genetically
modified mouse models to compliment the largely phar-
macological studies in this area to date. Thus, while the role
of Shh in wound repair is a relatively unexplored topic
compared to its role in skin development, the evidence
suggests that this is a promising area of future research.
Wound healing across the taxa
All organisms are exposed to environmental cues around
them. For a long life, multicellular organisms must main-
tain their tissue morphology and its function. The
environment is riddled with potential sources of harm—
from sharp surfaces to infectious organisms searching for
routes to penetrate an organism’s body armor. To deal with
these threats, multicellular organisms are equipped with a
strong waterproof barrier that protects them from physical
harm. All multicellular organisms are able to respond to
injury and repair their tissue to some extent. For example,
upon epidermal injury, a conserved innate immune system
functions in both vertebrates and invertebrates [144] to
combat infectious microbes. In order to preserve tissue
integrity, it is essential that organisms detect the loss of
tissue mass, activate the de novo production of cells, and
organize those cells into functional tissues. However, there
is huge diversity in how the process of healing occurs
across the taxa. Some multicellular organisms can regen-
erate the missing part of the body while others cannot. In
spite of this diversity, there are basic principles of healing
shared by many multicellular organisms: injury detection,
gap closure, cell division activation to supply new cells,
cell differentiation, and remodeling of newly formed tissue.
Even the earliest branching animals (e.g. the sponge
Oscarella carmela) express core components of the Wnt,
TGF-b, Notch and Hedgehog signaling pathways [145]. In
mammals, despite considerable ability for tissue regener-
ation, large wounds result in the formation of scar tissue
instead of a complete restoration of tissue morphology and
function [5]. This limited regenerative capacity is partly
due to rapid interposition of fibrotic tissue, something that
prevents subsequent tissue regeneration, but might be a
defensive advantage in preventing harmful microbes [5].
Tissue regeneration in humans, however, is very limited. If
injured, only bone, liver and infant finger tips can regen-
erate [70, 146, 147]. Aging is another determinant for
tissue restoration, as animals gradually lose their regener-
ative capacity as they get older. The diversity in tissue
restoration is due to the species, the type of injured tissue,
and the age of the animal. It seems that during vertebrate
evolution, some of the regenerative ability of lower mul-
ticellular organisms was inactivated.
As noted, core components of the Wnt, TGF-b, Notch
and Hedgehog signaling pathways are expressed in sponges
and higher organisms across the taxa [145]. Preservation of
signaling pathways across taxa requires a universal way by
which multicellular organisms respond to injury and heal
their bodies. If we are able to unveil the mechanism of
tissue preservation across the taxa, we may open new doors
for tissue/organ regeneration in humans, preferably by
enhancing our endogenous ability which was inactivated
during evolution. A clue may come from the following
nonmammalian species that have an impressive ability to
regenerate (Table 3).
Planarians
Planarians are a group of nonparasitic flatworms. They lack
complex organs but can fully regenerate [148]. A planarian
split lengthwise or crosswise will regenerate into two
separate individuals. Planarian regeneration involves
changes in preexisting tissues and the formation of an
outgrowth. It starts with the formation of a mass of pro-
liferating cells (blastema) at the site of injury. Blastema
cells become organized into tissue and regenerate organ
systems [148].
Table 3 Contribution of developmental signaling pathways to tissue healing (regeneration) in selected nonmammalian species
Animal group Wnt/b-catenin TGF-b Notch Hedgehog
Planarians Tail regeneration Tail regeneration
Fly Dorsal closure Dorsal closure
Fish Blastema formation Fin regeneration
Amphibians Tail regeneration, limb regeneration Tail regeneration Tail regeneration Tail regeneration
Empty cells indicate that there are no conclusive studies that support involvement of the indicated signaling pathway
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Small fragments of tissue (as little as 1 part in 289) [5]
can regenerate into entire new animals, including all
components of the body. When a planarian is cut trans-
versely, the caudal fragment will regenerate a head and the
anterior piece will regenerate a tail. It is has been shown
that after injury, Wnt signaling promotes tail regeneration.
In the head-versus-tail regeneration experiment, Wnt
inhibitor notum preferentially expresses at anterior-facing
wounds [149], highlighting the essential role of Wnt sig-
naling during planarian regeneration. Planarians depleted
of WntP-1 regenerate a head in place of a tail [150]. On the
other hand, Hedgehog signaling induces regeneration of a
tail instead of a head through the activation of Wnt tran-
scription [151, 152]. This suggests the importance of Wnt/
b-catenin and Hedgehog pathways for anteroposterior axis
specification during regeneration.
Fly
Mammalian skin and insect cuticle form a protective bar-
rier that helps prevent dehydration and protect against
injury. In the fruit fly Drosophila, this barrier has a single-
cell layer of epidermal cells that secrete cuticle. This
cuticle is equivalent to the stratum corneum in mammalian
skin, which consists of dead squamous epithelial cells.
Developments in genetic manipulation have allowed the
study of wound healing signaling pathways in fruit flies
which may provide new insights into biological processes,
including wound healing, in humans. Despite differences in
the molecular composition of insect cuticle and mamma-
lian skin, it is noteworthy that some regulatory mechanisms
for the development and healing of protective barriers in
insects and mammals have been conserved. For instance, a
master gene called grainy head (grh) activates wound
repair genes in the cells surrounding an injury in the cuticle
of fly embryos [153]. These wound repair genes then
regenerate the injured patch of cuticle. Wounds in mutant
flies that lack the grh gene fail to heal. Interestingly, the
grh gene is also essential for normal skin development and
wound repair in mice. Like their fruit fly counterparts, mice
lacking grh have a much more permeable skin than normal
mice, and also have deficient wound repair [154]. These
two studies signify an imperative concept in wound heal-
ing: although the structure of the surface barrier is
considerably different across taxa, the signaling pathways
that coordinate healing of the barrier are evolutionarily
conserved.
Morphological events such as dorsal closure [155] and
tracheal fusion [156] during Drosophila melanogaster
development, have notable similarity to wound repair in
humans. Dorsal closure of the Drosophila embryo is the
best-characterized example of epithelial sheet movement
leading to epithelial fusion. It involves migration of the
lateral epidermal flanks to close a hole in the dorsal epi-
dermis occupied by an epithelium [157]. Morphogenetic
events involving tissue migration and epithelial fusion have
been used as models to examine the involvement of
developmental signaling pathways in wound repair. Wnt/
Wingless (Wg) signaling has been shown to play an
essential role during dorsal closure [158]. Moreover, the
TGF-b signaling pathway is required for dorsal closure,
and acts downstream of the JNK cascade [159, 160]. These
signaling pathways regulate cytoskeletal reorganization
and cell shape change to orchestrate cell migration for
dorsal closure.
Fish
In some of the fish species, when a major part of the fin, or
even the entire fin, is removed, it is regenerated with
recovery of its shape and function [161]. Fish fins have
been used for analyzing the regeneration process for more
than two centuries [162]. Caudal fin regeneration is
dependent on the presence of musculature and endoskele-
ton at the site of amputation [161]. A layer of epidermal
cells covers the fin rays and the mesenchymal tissue around
them. Immediately after injury, an F-actin purse string is
formed in the epithelial cells surrounding the wound gap
and quickly contracts to close the epithelial opening [14].
Later, the epithelial cells migrate to make a tight epithelial
sealing on the wound gap. Wound closure is complete by
this stage. The process of cell proliferation starts and forms
a new epidermis (called wound epidermis) to cover the
wounded area. As in their mammal counterparts, this epi-
dermis layer is distinguishable from the surrounding
epidermis by its thick morphology [163]. Following the
formation of the wound epidermis, a mass of proliferating
mesenchymal cells forms (again called blastema). The
blastema (which is in close contact with the wound epi-
dermis) continues to proliferate until an adequate cell
supply is available to replace the lost part. In order to study
the developmental signaling pathways involved in healing,
different genetic methods or specific biochemical assays
have been used. Here, we discuss the role of some of the
above-mentioned signaling pathways during the fish heal-
ing process.
Amputating the caudal fin in zebrafish stimulates
regeneration of the dermal skeleton and re-expression of
Shh signaling pathway genes. The essential role of
Hedgehog signaling in bone differentiation in the fin-ray
has been demonstrated [164] using cyclopamine (an
inhibitor of Hedgehog signaling). Exposure to cyclopamine
alters bone patterning. FGF receptor 1 (FGFR1) is expres-
sed in mesenchymal cells underlying the wound epidermis
during blastema formation and in distal blastemal tissue
during regenerative outgrowth. Using SU5402 (an inhibitor
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of FGF signaling), blastemal cell proliferation is blocked,
leading to the prevention of outgrowth during ongoing fin
regeneration [165]. This shows the necessity of FGF sig-
naling for zebrafish fin blastema formation and regenerative
outgrowth. It is interesting to note that the Wnt/b-catenin
signaling acts upstream of FGF signaling [166]. The
importance of Wnt/b-catenin signaling has been shown
using transgenic fish lines. During zebrafish tail fin regen-
eration, Wnt/b-catenin signaling is activated and is required
for the formation, and subsequent proliferation, of the
blastema progenitor cells [166]. Using a dominant-negative
form of T cell factor (to transcriptionally block Wnt/b-
catenin signaling) or DKK1 (to block Wnt/b-catenin sig-
naling at the ligand level), this essential role of the Wnt
signaling pathway was highlighted [166]. Furthermore,
MMP inhibitors also inhibit the regeneration process and
result in reduced cell proliferation in the blastema [167].
Studies over the last few decades have shown the critical
role of some of these developmental signaling pathways
during fish regeneration and have advanced our under-
standing of how activation of these pathways in a timely
manner leads to tail fin regeneration.
Amphibians
Some species of amphibians, a class of vertebrates
including frogs and salamanders, have the ability to
regenerate amputated appendages through the formation of
a blastema. While the origin of blastema cells is unclear, in
urodeles, it has been suggested that the blastema is formed
by the de-differentiation of nearby cells [168, 169]. This
highlights the existence of plastic residual differentiated
cells rather than the existence of so-called ‘‘reserve stem
cells’’ [170]. However, using a lineage-tracing approach in
the salamander, each tissue produces progenitor cells with
restricted potential [171]. While this challenges the exis-
tence of a unique cell with multipotential regenerative
capacity, it nonetheless reveals the fabulous endogenous
regenerative machinery that is partly inactivated in
humans. Adult urodele amphibians can restore limbs, tails,
the lens and retina of the eyes, and heart tissue [172]. This
remarkable ability, together with the close relationship
between amphibians and mammals, makes amphibians a
very attractive model for the study of regeneration.
The importance of several developmental signaling
pathways has been shown in recent studies on Xenopus.
Wnt signaling inhibition using DKK1 at the beginning of
regeneration is sufficient to efficiently inhibit both tail and
limb regeneration in Xenopus [173]. Likewise, using BIO
(a cell-permeable compound that acts as a highly potent
ATP-competitive inhibitor of GSK-3a/b [174]) as an
enhancer for the Wnt/b-catenin signaling pathway causes
blastema cell proliferation to increase and leads to
enhanced outgrowth of the regenerating tail [175]. Notch
signaling is also necessary for tail regeneration in Xenopus.
Blocking Notch signaling with the protease inhibitor
MG132 (which inhibits the cleavage of the NCID) blocks
tail regeneration [176], suggesting involvement of the
Notch signaling pathway in tail regeneration. However,
considering the nonselective effect of this protease inhibi-
tor, the specific targeting of the Notch pathway using this
compound remains to be defined.
In Xenopus, the notochord provides a source of Shh to
the cells near the amputation site. Therefore, it is conceiv-
able that the availability of Shh in the stump tissues
determines the regenerative potential of each amputated
site. In support of this, treatment with cyclopamine (the Shh
signaling inhibitor) has been shown to prevent tail regen-
eration in urodeles [177]. However, unlike tail regeneration,
cyclopamine-treated regenerating limbs attain a normal
length and contain cartilage [177]. This shows that temporal
and spatial expression of morphogens during development
may give a clue as to which developmental signaling
pathway plays the crucial role for the regeneration of each
organ. TGF-b signaling has been shown to play a vital role
in wound healing of the tail [178]. Amputated animal tails
that are treated immediately and continuously with SB-
431542 (a TGF-b-specific inhibitor) fail to form a wound
epidermis and tail regeneration is blocked [178].
Unlike most amphibians which undergo metamorphosis
(from egg to larva and larva to adult form), in a condition
called neoteny, the axolotl continues to show larval fea-
tures throughout its life, retaining external gills and with
undeveloped limbs [179]. These paedomorphic axolotls are
fully aquatic, sexually mature and fail to completely
metamorphose. Moreover, they are capable of flawlessly
repairing full-thickness excisional wounds made on their
dorsal flank [179]. A study comparing skin regeneration
between paedomorphic and metamorphic axolotls (by
induction of metamorphosis in adult axolotls) has shown
that aquatic (paedomorphic) axolotls re-epithelialize faster,
have fewer leukocytes during early inflammation, have less
ECM deposition and a faster regeneration (two times faster
for complete skin regeneration) [180]. This highlights the
relationship between retention of larval characteristics (i.e.
paedomorphic axolotls) with the process of regeneration
(faster regeneration) as observed in other vertebrates [181].
However, the fact that both paedomorphic and metamor-
phic axolotls are capable of scar-free healing (with a delay
in metamorphic axolotls) implies that ultimately both
paedomorphic and metamorphic axolotls are able to revert
to the earlier stage of development to regenerate, sug-
gesting an intrinsic capability in cells regardless of their
larval stage. Unraveling this intrinsic capability might be
the key for scarless skin healing and complete regeneration
in humans.
Cutaneous healing: developmental pathways 2071
123
Clinical aspects of wound healing in humans:
perspective
The human skin forms a large physical barrier between the
body and its environment. Skin diseases can have many
mental and physical effects on the quality and length of life
[182]. Likewise, deficient wound healing may impose huge
mental and physical burdens on patients. It has been
reported that about 15 % of older adults suffer from chronic
wounds [183]. Furthermore, every 30 seconds, a lower limb
is lost somewhere in the world as result of wound infection
[183]. This not only affects the personal life of the indi-
vidual, but also has a huge economic effect on society. The
burden of treating wounds with deficient healing is growing
rapidly due to escalating health-care costs, aging popula-
tions, and a sharp increase worldwide in the incidence of
diseases such as diabetes. In the US alone, the collective
health-care cost of chronic wounds is estimated at $25
billion annually [184]. The annual wound care products
market reached $15 billion in 2010 [183]. These factors all
impose a great cost on society, and emphasize the necessity
for better management of deficient wound healing. One
strategy is to develop therapies that manipulate the devel-
opmental signaling pathways discussed above in an attempt
to recapitulate wound repair observed during fetal healing
and the process of regeneration.
While some wound healing complications are due to
delayed healing, occurring in patients with diabetes,
immunodeficiency, or radiation exposure, some complica-
tions are also due to excessive healing, such as
hypertrophic and keloid scarring [5]. Such scarring causes
morbidity, particularly when the scar is close to a vital
organ or if it limits the motion of a joint. Hypertrophic
scars mainly occur after major injuries such as burns,
leading to poorly structured skin with cosmetic and medi-
cal consequences. On the other hand, keloid scars are
tough, heaped-up scars that rise quite suddenly above the
skin for unknown reasons after a minor injury. They tend to
enlarge progressively and occur with a familial tendency
[185]. Some keloids arise from a mature scar some years
after the initiating events [185]. Several studies have
investigated the contribution of molecules in the SMAD-
dependent TGF-b signaling pathways at both the mRNA
and protein levels in keloids [186–189]. It is intriguing that
TGF-b has been shown to upregulate the Wnt/b-catenin
pathway in hypertrophic scars and keloids [53, 56, 61].
Moreover, in skin organotypic culture, R-spondin2 (a
secreted protein known to be a Wnt/b-catenin signaling
agonist [190]) thickens the epidermis, a hyperproliferative
phenotype observed in keloids [191]. These studies suggest
a role for Wnt/b-catenin signaling in the pathogenesis of
keloids. Although no direct involvement of the Hedgehog
and Notch signaling pathways in keloid pathogenesis has
been suggested, Gli-1 has been shown to be upregulated in
keloids [192].
For decades, growth factors were the main focus of
research. Several studies have tried to identify the role of
growth factors during skin healing, mainly considering
wound healing enhancers [193, 194]. This has made growth
factors the core of the therapeutic approach for disturbed
healing, which has in turn led to several double-blind trials
using different growth factors in humans. Some of these
trials have shown promising preliminary results, but none
of the growth factors has been approved for clinical use
[14, 15, 195–197]. A correlation exists between increased
amounts of TGF-b and fibroblast hyperproliferation during
hypertrophic scarring [66, 198, 199]. On this basis, clinical
studies were designed to decrease scar formation using
antibodies or molecules directed against TGF-b [200]. For
example, early work investigating the application of
exogenous TGF-b2 to venous stasis ulcers was promising
[201]. Recently, a phase II clinical trial study showed that
intradermal TGF-b3 administration following scar revision
surgery significantly improved scar appearance compared
with a placebo [202]. However as noted, it did not meet the
expected endpoints in phase III clinical trials [119].
A TGF-b antagonist increased the speed of re-epitheliali-
zation and reduced scar formation and wound contraction
in a partial thickness burn experiment in pigs [105]. While
the recent trend seems promising, multiple well-designed
clinical trials will be indispensable to evaluating the effi-
ciency of TGF-b components for the management of
deficient wounds. This is because multiple clinical trials
have failed to show the efficiency of TGF-b in the treat-
ment of chronic wounds [76].
To date, only human recombinant PDGF-BB has
received FDA approval for the management of limb dia-
betic ulcers [203], and ulcers treated with PDGF-BB
showed only a 15 % greater healing incidence compared to
placebo-treated ulcers [203–205]. Moreover, in 2008 the
FDA warned of an increased risk of cancer mortality in
patients who need extensive treatment with PDGF-BB.
There are also some reports on the anti-scarring effects of
FGF-2, including in clinical use [206]. Postoperative
administration of FGF-2 inhibits hypertrophy and widening
of scars without any serious side effects. Indeed, in Japan,
FGF-2 is already used clinically. Moreover, there are some
reports which highlight the clinical advantage of using EGF
during recovery from life-threatening conditions [207].
In spite of all these advances, these approaches have not
led to substantial changes in patient care. It is likely that
limited success in single-factor therapies is due to their
off-target effects, the difficulty in correctly timing their
administration during healing, and the dynamic nature of
the wound healing process. In addition, the interactions
among growth factors, their receptors, and other ECM
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components are also critical for the clinical delivery of
growth factors. Studies in a diabetic mouse model of
chronic wounds have shown that an engineered form of
recombinant fibronectin greatly enhances the regenerative
effects of administered growth factors [208]. This suggests
that combination therapy may tackle some barriers in the
management of disturbed wound healing. An alternative
approach to wound management would be to use cells that
contribute to normal healing. Providing the cells whose
contribution in normal wound healing is known together
with the correct microenvironmental elements that are
important for these cells to thrive, could be a feasible
alternative approach in the management of deficient skin
healing. Therefore, finding the origin of cells that con-
tribute to normal skin wound healing may open new doors
to candidate cell therapy sources, and these cells could
potentially be sources of growth factors as well [60].
Approaches that are currently available to optimize
wound repair include refinements in surgical technique,
nutritional supplementation, and the use of local wound
care modalities [209]. Despite these approaches, there has
been little progress in the ability to regulate wound size.
Surgical advances have helped minimize deficient skin
healing following surgery, but scar formation is still just a
minimal cost of surgery. Laser technology has evolved
over the past few decades and may be useful in the treat-
ment of select scars [210, 211]. However, more research is
needed with less bias, better-defined laser settings, better
outcome measurement characteristics, and standardized
measuring methods to evaluate outcomes in humans.
Animal models and in vitro experiments have also shown
that lasers can facilitate rapid resolution of cutaneous
ulceration, although this has yet to be consistently observed
in humans.
The laser was first used as a surgical tool shortly after its
invention as an alternative to mechanical surgical tools
[212]. As a cutting modality, lasers can perform surgery at
the fundamental limit by exploiting the spatial phase
coherence of laser radiation to focus sufficient intensity for
ablation or cutting at the single cell level. A recent study
has shown that, in mouse wound healing, a new laser is
able to ablate tissue at the single cell level [69]. Of par-
ticular note, the smaller scar size in tissue ablation is
accompanied by less Wnt/b-catenin and TGFb signaling
pathway activation [69]. This tackles part of the problem
that exists with thermal lasers [213].
Despite all these advances, the ultimate standard for
management of deficient skin healing is to prove the rele-
vance of animal wound healing research to humans.
Effective therapeutic and preventive strategies depend on
our understanding of wound healing, the biology of scar
formation, and the cells that contribute to the healing
process. This may be achieved by elucidating the
molecular pathways whereby adult cutaneous healing dif-
fers from embryonic skin development and regeneration.
The ultimate goals should be the transformation of fibrotic
events into regenerative events in the case of over-scarring,
as well as the provision of cells (and cell niche) to
regenerate in the case of non-healing. Studying the devel-
opmental signaling pathways that are essential for wound
healing and manipulating them at the right time during the
course of wound healing may be a strategy for tackling
some complications. The vast social and economic impact
of disturbed wound healing calls for the allocation of more
resources to identify biological mechanisms underlying the
complexities of wound healing.
Conclusions and future directions
Here we have discussed the roles of several key develop-
mental signaling pathways (Wnt/b-catenin, TGF-b, Notch,
Hedgehog) in mammalian cutaneous wound repair and
compared them with their functions in embryonic skin
development and regeneration. The Wnt/b-catenin, Notch,
Hedgehog and TGF-b families are well characterized as
major regulators of developmental processes. The TGF-b
pathway in turn is infamous as a mediator of cutaneous
healing. Because of the parallels between skin healing and
embryonic skin development, a review of the research
concerning the roles of these developmental signaling
pathways in cutaneous wound repair has the potential to
generate new perspectives for these events. Although both
skin repair and development are designed to construct skin,
they have very different outcomes in mammals. The prop-
erties of the scar tissue produced by cutaneous wound repair
differ substantially from the skin we are born with. Insights
into the relationship between skin repair and development
may be harnessed to generate new therapies for treating
wound healing disorders. Similarly, understanding the sig-
naling events that regulate healing in species with the ability
to completely regenerate their damaged tissue may suggest
strategies for improving wound healing outcomes in
humans. To achieve these goals, future research should aim
to elucidate the mechanisms which differentiate mamma-
lian skin repair from skin development and regeneration.
The inflammatory response constitutes one of the
key differences between cutaneous wound repair and
embryonic skin development in mammals. While the
inflammatory response is crucial to protect the organism
from infection and further harm, it is also a major factor in
the pathogenesis of scar formation. As discussed above, the
actions of inflammatory cells and their cytokines released
during wound repair contribute to fibrosis and the formation
of scar tissue. The aim of clinical therapies should be to
achieve an optimal balance between the protective function
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of inflammation and the prevention of excessive scar tissue
formation. This may be achieved by enhancing our under-
standing of how and when developmental and other
signaling pathways interact during inflammation and in the
transition to the proliferative phase of healing. For example,
some growth factors and ECM components are present at
different concentrations in scar-less fetal repair versus adult
healing [4, 6, 9]. Further insight into the mechanisms that
regulate the transition in the wound milieu between the
fetus and adult may allow manipulation of signaling
mediators to mimic the embryonic environment.
In general, the developmental signaling pathways dis-
cussed here have been more extensively investigated in the
context of developmental biology than in wound repair.
However, it is clear that many of these pathways play
parallel or similar roles in both processes. As these sig-
naling pathways are involved in complex epithelial–
mesenchymal crosstalk during development, it is impera-
tive to further investigate such interactions between
different cellular compartments during cutaneous wound
healing. Related to this is the concept of crosstalk between
cells and their microenvironment or niche [16], a subject of
intense interest, particularly in the fields of developmental
biology, stem cell, and cancer research. As a recent
example from our laboratory shows in terms of the influ-
ence of fibronectin on fibroblast behavior [62], these
interactions also take place during wound repair. Directions
for future research thus include further investigating
crosstalk between different cell types (including skin stem
cells) and compartments, and between cells and the ECM,
during the wound repair process. The wound is a dynamic
environment and achieving a complete understanding of
the nature of these relationships, which may occasionally
be fluid or transient, is certainly a challenging task. How-
ever, it is also an important area of investigation if we are
to fully understand the mechanisms that regulate skin
repair and those that regulate development.
Finally, while we have discussed only a few key
developmental signaling pathways in this review, a multi-
tude of other signaling mediators participate in wound
repair, development, and regeneration, some of which may
not yet have been identified. Insight into the identities of
the molecules and pathways that may account for differ-
ences between postnatal and fetal healing has been aided
by high-throughput approaches, such as expression array
analysis [214, 215]. Although gene expression studies are
valuable in identifying candidates, they should be com-
bined with proteomics approaches to uncover possible
variations in protein synthesis or modification between
subjects. The role of microRNAs in regulating wound
repair [216] is another emerging topic of exploration that
may elucidate some of the regulators in adult and fetal
healing. While such mass-throughput approaches certainly
represent a valuable means of filtering information and
identifying possible targets for further analysis, it is
important that the interactions of candidate molecules and
signaling pathways be validated in vivo. The complex and
dynamic wound environment cannot be completely reca-
pitulated in vitro, but can be most thoroughly examined in
its natural in vivo setting where all of the required factors,
both known and unknown, are present.
The intricate and dynamic nature of the wound envi-
ronment suggests that successful therapies for treating
wound healing disorders will not rely upon a single all-
encompassing agent, but will likely require a multitude of
factors administered at different periods during the wound
healing process. Identifying the relationships between
developmental signaling pathways in adult wound repair
and fetal skin development and/or regeneration will cer-
tainly propel the research community closer to this goal,
and is a fruitful area of future investigation.
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